Nuveen Asset Management, LLC 10x Genomics, Inc. Transaction History

Nuveen Asset Management, LLC

  • $345 Billion
  • Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 201,134 shares of TXG stock, worth $3.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
201,134
Previous 267,678 24.86%
Holding current value
$3.2 Million
Previous $5.21 Million 12.77%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$15.71 - $23.49 $1.05 Million - $1.56 Million
-66,544 Reduced 24.86%
201,134 $4.54 Million
Q2 2024

Aug 09, 2024
BUY
$19.45 - $37.37 $299,102 - $574,675
15,378 Added 6.1%
267,678 $5.21 Million
Q1 2024

May 13, 2024
BUY
$36.08 - $54.3 $25,147 - $37,847
697 Added 0.28%
252,300 $9.47 Million
Q4 2023

Feb 14, 2024
BUY
$34.32 - $57.55 $2.13 Million - $3.57 Million
61,981 Added 32.69%
251,603 $14.1 Million
Q3 2023

Nov 14, 2023
SELL
$40.86 - $62.98 $2.66 Million - $4.09 Million
-65,016 Reduced 25.53%
189,622 $7.82 Million
Q2 2023

Aug 14, 2023
SELL
$50.96 - $58.72 $101,818 - $117,322
-1,998 Reduced 0.78%
254,638 $14.2 Million
Q1 2023

May 15, 2023
BUY
$35.33 - $55.79 $1.32 Million - $2.08 Million
37,298 Added 17.0%
256,636 $14.3 Million
Q4 2022

Feb 14, 2023
SELL
$24.4 - $41.3 $135,005 - $228,512
-5,533 Reduced 2.46%
219,338 $7.99 Million
Q3 2022

Nov 14, 2022
SELL
$28.48 - $52.59 $279,958 - $516,959
-9,830 Reduced 4.19%
224,871 $6.4 Million
Q2 2022

Aug 15, 2022
BUY
$36.95 - $82.41 $1.14 Million - $2.54 Million
30,784 Added 15.1%
234,701 $10.6 Million
Q1 2022

May 16, 2022
BUY
$55.7 - $145.79 $436,966 - $1.14 Million
7,845 Added 4.0%
203,917 $13.6 Million
Q4 2021

Feb 14, 2022
SELL
$135.05 - $182.59 $1.36 Million - $1.84 Million
-10,058 Reduced 4.88%
196,072 $29.2 Million
Q3 2021

Nov 12, 2021
SELL
$145.58 - $192.14 $65.4 Million - $86.4 Million
-449,489 Reduced 68.56%
206,130 $30 Million
Q2 2021

Aug 16, 2021
SELL
$134.22 - $202.37 $52.9 Million - $79.8 Million
-394,107 Reduced 37.54%
655,619 $128 Million
Q1 2021

May 17, 2021
SELL
$140.25 - $196.86 $4.35 Million - $6.11 Million
-31,019 Reduced 2.87%
1,049,726 $190 Million
Q4 2020

Feb 16, 2021
BUY
$126.47 - $163.7 $10 Million - $13 Million
79,339 Added 7.92%
1,080,745 $153 Million
Q3 2020

Nov 16, 2020
BUY
$87.44 - $125.0 $59.6 Million - $85.2 Million
681,250 Added 212.79%
1,001,406 $125 Million
Q2 2020

Aug 14, 2020
BUY
$58.39 - $89.31 $18.7 Million - $28.6 Million
320,156 New
320,156 $27.1 Million

Others Institutions Holding TXG

# of Institutions
291
Shares Held
94.7M
Call Options Held
263K
Put Options Held
85.1K
View Full List

About 10x Genomics, Inc.

TXG Quotes by TradingView
  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.51B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email